The brightest star in Boston’s rapidly growing biotech scene isn’t a flashy new player, but rather one of its longest standing companies. While many biotech stocks have struggled this year ...

China is now setting the pace in life sciences R&D, conducting more clinical trials than the U.S. and licensing new ...

Biotech leaders have been warning about this washout, and small companies across the country, including in Boston, have already resorted to layoffs or dropped experimental drug programs to buy ...

The company will engage in BIO One-on-One Partnering™ meetings as it advances Phase 1 for Ketamir-2, prepares Phase IIa study ...

Boston Scientific is pulling its latest transcatheter aortic heart valve platform from the worldwide market and said it will ...

“Lots of companies are limping along,” said Mani Foroohar, senior research analyst at Boston health care investment bank Leerink Partners. Foroohar, a top biotech analyst, has slapped an ...

The slowdown has caused pain this year for companies from biotech startups to spec developers, but experts say the Boston market still has strong fundamentals and they are optimistic it will ...

The greater Boston area is home to close to one thousand biotech companies. While Boston has long been a center of the life sciences, it has largely expanded thanks to huge government investments ...

Nowhere near the stratosphere of Boston. All these factors make it ... Fujifilm is one of several big biotech companies that have moved to Holly Springs, a growing town about a half hour from ...

The Boston-based cell programming and biosecurity company had said the cuts were coming during quarterly earnings call earlier this year. Ginkgo Bioworks Holdings Inc. is headquartered in the ...

Andrew Krenning is the associate managing director of the Boston office ... Engineers (ASHRAE), the International Society for Pharmaceutical Engineering (ISPE), New England Healthcare Engineers ...

The brightest star in Boston’s rapidly growing biotech scene isn’t a flashy new player, but rather one of its longest standing companies. While many biotech stocks have struggled this year ...